https://www.selleckchem.com/pr....oducts/trastuzumab-d
There were significant differences in SUV and RE between F0 and F3-4 and between F1-2 and F3-4 (p0.01), but no significance between F0 and F1-2 (p0.5). Combined SUV and RE performed well in staging liver fibrosis, with AUC of 0.8 for F0 or greater, 0.744 for F0 or F1-2, 0.945 for F1-2 or F3-4, and 0.962 for F3-4. Combining SUV and RE provides high accuracy for grading liver fibrosis, especially in the differentiation between F1-2 and F3-4. F-FDG and Gd-EOB-DTPA-enhanced PET/MRI could be a non-invasive diagnostic m
Beğen
Yorum Yap
Paylaş
